Key result
Robotic assistance improves exercise capacity, VO2 max, and LVEF versus standard care in cardiac disease.
Why the study?
While robotics has clear benefits in neuro-musculoskeletal rehabilitation, it is unknown whether robotics will also enhance cardiac rehabilitation outcomes.
Do robotic assistance technologies improve exercise capacity, VO2 max/peak, LVEF, QOL, and physical functioning in people with cardiac diseases undergoing cardiac rehabilitation?
Systematic Review (n=4)
Do robotic assistance technologies improve exercise capacity, VO2 max/peak, LVEF, QOL, and physical functioning in people with cardiac diseases undergoing cardiac rehabilitation?
Robotic assistance technologies in cardiac rehabilitation programs appear to improve exercise capacity, LVEF, and quality of life, though further studies are needed to confirm superiority over standard interventions.
Robotic assistance may improve CR outcomes; leaves open superiority over standard care, requiring larger confirmatory trials.
Background and Objectives: Robotics is commonly used in the rehabilitation of neuro-musculoskeletal injuries and diseases. While in these conditions, robotics has clear benefits, it is unknown whether robotics will also enhance the outcome of cardiac rehabilitation. This systematic review evaluates the use of robotics in cardiac rehabilitation. Methods: A systematic literature search was conducted using PubMed (MEDLINE), CINAHL, AMED, SPORTDiscus, and the Physiotherapy Evidence Database. Longitudinal interventional studies were included if they met specified criteria. Two reviewers independently conducted title, abstract, and full-text screening and data extraction. The quality assessment and risk of bias were conducted according to the PEDRO scale and Cochrane Risk of Bias tool 2, respectively. Results: Four trials were included in this review out of 60 screened studies. The quality of the included studies was good with a low risk of bias. The trials used different robotic systems: Lokomat® system, Motomed Letto/Thera Trainer tigo, BEAR, and Myosuit. It was found that interventions that included the use of robotic assistance technologies improved the exercise capacity, VO2 max/peak, left ventricular ejection fraction, QOL, and physical functioning in people with cardiac diseases. Conclusions: Robotic assistance technologies can be used in cardiac rehabilitation programs. Further studies are needed to confirm the results and determine whether the use of robotics enhances intervention outcomes above standard interventions.
No takes yet. Share an insight, caveat, or question.
Aburub et al. (2024) conducted a systematic review in Cardiac diseases (n=4). Robotic assistance technologies was evaluated on Exercise capacity, VO2 max/peak, left ventricular ejection fraction, QOL, and physical functioning. A systematic review of 4 trials found that robotic assistance technologies improved exercise capacity, VO2 max/peak, left ventricular ejection fraction, and physical functioning in cardiac diseases.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: